Cargando…

Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease

Detalles Bibliográficos
Autor principal: Jeong, Woo Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593318/
https://www.ncbi.nlm.nih.gov/pubmed/28874039
http://dx.doi.org/10.5009/gnl17333
_version_ 1783263018627366912
author Jeong, Woo Kyoung
author_facet Jeong, Woo Kyoung
author_sort Jeong, Woo Kyoung
collection PubMed
description
format Online
Article
Text
id pubmed-5593318
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-55933182017-09-13 Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease Jeong, Woo Kyoung Gut Liver Editorial Editorial Office of Gut and Liver 2017-09 2017-09-15 /pmc/articles/PMC5593318/ /pubmed/28874039 http://dx.doi.org/10.5009/gnl17333 Text en Copyright © 2017 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Jeong, Woo Kyoung
Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
title Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
title_full Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
title_fullStr Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
title_full_unstemmed Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
title_short Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
title_sort hepatic and splenic volumetry could be used as an imaging parameter to evaluate fibrosis grades of the diffuse liver disease including nonalcoholic fatty liver disease
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593318/
https://www.ncbi.nlm.nih.gov/pubmed/28874039
http://dx.doi.org/10.5009/gnl17333
work_keys_str_mv AT jeongwookyoung hepaticandsplenicvolumetrycouldbeusedasanimagingparametertoevaluatefibrosisgradesofthediffuseliverdiseaseincludingnonalcoholicfattyliverdisease